Chiba University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Chiba University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9333
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Chiba University (Chiba) is an educational university that offers undergraduate education, short-term study program, graduation, double degree program, global COE program, good practice program, distinctive education and research, and international collaborative research program. The university offers courses in the fields of economics, science, medicine, medical and pharmaceutical sciences, nursing, social sciences, pharmaceutical sciences, law, engineering and horticulture, among others. Chiba University conducts research promotion program in mucosal immunology and allergy therapeutics, hadron astrophysics, medical engineering, phytochemical plant molecular sciences, and others. Chiba offers university library, university hospital and other educational and research facilities. It also provides short term programs for foreign university students. The university has operations in Chiba and Kashiwa. Chiba is headquartered in Chiba, Japan.

Chiba University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Chiba University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chiba University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chiba University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chiba University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Chiba University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Chiba University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 10
D.Western Therapeutics Institute Enters into Research Agreement with Chiba University 12
Licensing Agreements 13
Japan Agency for Medical Research and Development Enters into Licensing Agreement with Chiba University 13
Chiba University – Key Competitors 14
Chiba University – Key Employees 15
Chiba University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Chiba University, Pharmaceuticals & Healthcare, Key Facts 2
Chiba University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chiba University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Chiba University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chiba University, Deals By Therapy Area, 2012 to YTD 2018 8
Chiba University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Astellas Pharma, Institute of Medical Science, Chiba University and Asahi Kogyosha Enter into Research Agreement 10
D.Western Therapeutics Institute Enters into Research Agreement with Chiba University 12
Japan Agency for Medical Research and Development Enters into Licensing Agreement with Chiba University 13
Chiba University, Key Competitors 14
Chiba University, Key Employees 15
Chiba University, Other Locations 16
Chiba University, Subsidiaries 16

List of Figures
Chiba University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Chiba University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Chiba University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Chiba University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Chiba University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Chiba University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Chiba University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Chiba University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Chiba University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Las Vegas Sands Corp:企業の戦略・SWOT・財務情報
    Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report Summary Las Vegas Sands Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Ultimovacs AS-製薬・医療分野:企業M&A・提携分析
    Summary Ultimovacs AS (Ultimovacs) is a provider of novel immunotherapies for cancer treatment. The company develops synthetic peptide based therapeutic vaccines that can be used on its own and also in combination with conventional therapies such as surgery, chemotherapy, and irradiation. Its UV1 is …
  • Redington (India) Ltd (REDINGTON):企業の財務・戦略的SWOT分析
    Redington (India) Ltd (REDINGTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Unibail-Rodamco-Westfield Se:企業の戦略・SWOT・財務分析
    Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report Summary Unibail-Rodamco-Westfield Se - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Noni B Ltd (NBL):企業の財務・戦略的SWOT分析
    Noni B Ltd (NBL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Chiba University:製薬・医療:M&Aディール及び事業提携情報
    Summary Chiba University (Chiba) is an educational university that offers undergraduate education, short-term study program, graduation, double degree program, global COE program, good practice program, distinctive education and research, and international collaborative research program. The univers …
  • Firmenich SA:企業の戦略的SWOT分析
    Firmenich SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • TIS Inc (3626):企業の財務・戦略的SWOT分析
    TIS Inc (3626) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • NAPEC Inc:電力:M&Aディール及び事業提携情報
    Summary NAPEC Inc (NAPEC), is a subsidiary of Oaktree Capital Management, L.P., is an energy services company that provides construction and maintenance services. It builds and maintains electrical transmission and distribution systems, solar panel farms, and natural gas networks. The company instal …
  • CEMEX, SAB de CV:企業の戦略・SWOT・財務分析
    CEMEX, SAB de CV - Strategy, SWOT and Corporate Finance Report Summary CEMEX, SAB de CV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Hertz Global Holdings Inc:企業の戦略・SWOT・財務情報
    Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Hertz Global Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tektronix, Inc.:企業の戦略・SWOT・財務分析
    Tektronix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Tektronix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cosmo Bio Co Ltd (3386):企業の財務・戦略的SWOT分析
    Summary Cosmo Bio Co Ltd (Cosmo Bio) operates as a medical device company that offers markets research reagents and research instruments. The company’s product categories include antibodies, assay and detection, cells and cell culture, bioactive substances, protein engineering, separation and purifi …
  • Welltower Inc
    Welltower Inc - Strategy, SWOT and Corporate Finance Report Summary Welltower Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Indeck Energy Services Inc:企業の発電所・SWOT分析2018
    Indeck Energy Services Inc - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key em …
  • Gexa Energy LP:企業の戦略的SWOT分析
    Gexa Energy LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • CPR Pharma Services Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary CPR Pharma Services Pty Ltd (CPR) is a contract research organization that offers drug development and clinical trial services. The organization's services include clinical project management and monitoring, data management, statistical and pharmacokinetic services, and bioanalytical service …
  • Netflix, Inc.:企業の戦略・SWOT・財務情報
    Netflix, Inc. - Strategy, SWOT and Corporate Finance Report Summary Netflix, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • AB Volvo:企業の戦略・SWOT・財務分析
    AB Volvo - Strategy, SWOT and Corporate Finance Report Summary AB Volvo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Dart Group PLC:企業の戦略・SWOT・財務情報
    Dart Group PLC - Strategy, SWOT and Corporate Finance Report Summary Dart Group PLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆